POSIEDZENIE NAUKOWE I SPRAWOZDAWCZO-WYBORCZE ODDZIAŁU KRAKOWSKIEGO POLSKIEGO TOWARZYSTWA UROLOGICZNEGO (OK PTU)
- PRE-CONFERENCE
- 13:00 - 15:00
- 120 min
- room - SYNERGIA 1
Wprowadzenie
- PRE-CONFERENCE
13.00-13.05
Ratująca endoskopowa prostatektomia u chorych na miejscowo zaawansowanego raka stercza: czy jest możliwa, a jeśli tak to czy jest korzystna?
- PRE-CONFERENCE
13.05-13.13
Miejsce nowoczesnej immunoterapii w leczeniu chorych na nowotwory urotelialne
- PRE-CONFERENCE
13.13-13.28
Znaczenie nowoczesnych materiałów szewnych oraz hemostatycznych w urologii XXI wieku
- PRE-CONFERENCE
13.28-13.43
Otyłość sarkopeniczna jako czynnik prognostyczny nowotworów urologicznych
- PRE-CONFERENCE
13.43-13.51
Uraz penetrujący moszny i krocza oraz możliwe powikłania
- PRE-CONFERENCE
13.51-13.59
Późny przerzut czerniaka do pęcherza moczowego wyglądający jak pierwotny guz pęcherza
- PRE-CONFERENCE
13.59-14.07
Zapalenie stercza
- PRE-CONFERENCE
14.07-14.15
Choroba Peyronie’go
- PRE-CONFERENCE
14.15-14.23
Endoskopowe rozpoznawanie kamicy układu moczowego
- PRE-CONFERENCE
14.23-14.31
25 lat Oddziału Urologii Szpitala Specjalistycznego im. L. Rydygiera w Krakowie
- PRE-CONFERENCE
14.31-14.39
Zebranie sprawozdawczo-wyborcze Oddziału Krakowskiego PTU
- PRE-CONFERENCE
14.47-15.00
XVII Spotkanie Urologów w Krynicy
- PRE-CONFERENCE
14.39-14.47
SPOTKANIE SEKCJI ADEPTÓW UROLOGII PTU
- PRE-CONFERENCE
- 13:00 - 15:00
- 120 min
- room - SYNERGIA 3
Wprowadzenie
- PRE-CONFERENCE
13.00-13.20
Struktura i działalność SAU PTU obecnie i przyszłości. Znaczenie SAU PTU w Polsce i w Europie
- PRE-CONFERENCE
13.20-13.45
Nowe zasady zdawania egzaminu ustnego w dziedzinie urologii (EBU/PTU)
- PRE-CONFERENCE
13.45-14.10
Badania rejestrowe w urologii
- PRE-CONFERENCE
Zebranie sprawozdawczo-wyborcze SAU PTU
- PRE-CONFERENCE
14.10-14.35
Podsumowanie i zakończenia spotkania
- PRE-CONFERENCE
14.35-15.00
WELCOME COFFEE
- BREAK
- 14:15 - 15:15
- 60 min
INTERNATIONAL WORKSHOPS
- WORKSHOP
W1: Hands-on - laparoscopy
- WORKSHOP
- 15:15 - 16:45
- 90 min
- room - HARMONIA 3
W2: Hands-on - laparoscopy
- WORKSHOP
- 15:15 - 16:45
- 90 min
- room - HARMONIA 2
W3: Case - based management of metastatic kidney cancer
- WORKSHOP
- 15:15 - 16:45
- 90 min
- room - HARMONIA 1
W4: Case - based management of metastatic prostate cancer
- WORKSHOP
- 15:15 - 16:45
- 90 min
- room - SYNERGIA 3
W5: Case - based urological reconstruction
- WORKSHOP
- 15:15 - 16:45
- 90 min
- room - SYNERGIA 1
BREAK
- BREAK
- 16:45 - 17:00
- 15 min
MODERATED POSTER SESSION (20 BEST POSTERS)
- POSTER SESSION
- 17:00 - 19:00
- 120 min
- room - HARMONIA 1
MMP-7 is a validated prognostic biomarker of disease progression in urothelial carcinoma: a combined cohort analysis, systematic review and meta-analysis
- POSTER SESSION
Functional outcomes in female patients after traditional, organ- and nerve-sparing radical cystectomy and urinary diversion for bladder cancer: a systematic review and pooled analyses
- POSTER SESSION
PARP inhibitor’s efficacy is comparable to platinum chemotherapy in BRCA1/2 positive metastatic castration-resistant prostate cancer – a systematic review and meta-analysis
- POSTER SESSION
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer
- POSTER SESSION
Discontinuation of immune-oncology combinations due to immune-related adverse events: impact on survival of patients with advanced renal cell carcinoma
- POSTER SESSION
DNA damage repair gene alterations in cisplatin based neoadjuvant chemotherapy in muscle invasive bladder cancer
- POSTER SESSION
Survival outcomes of patients treated with local therapy for non-metastatic prostate cancer with high PSA levels
- POSTER SESSION
PSMA PET/CT in Primary Staging of High-risk Prostate Cancer
- POSTER SESSION
Serum cfDNA analysis identified UCA1 copy number gain as a predictive biomarker of enzalutamide resistance in metastatic castration-resistant prostate cancer
- POSTER SESSION
Systematic molecular analysis identified NCAPH, ZWINT and UBE2C as novel prognostic tissue biomarkers in clinically localized prostate cancer
- POSTER SESSION
Radical prostatectomy with extended pelvic lymphadenectomy: impact of separate vs en bloc lymph node submission on diagnosis of lymph node metastasis
- POSTER SESSION
Blood-based biomarkers as prognostic factors of recurrent disease after radical cystectomy: a systematic review and meta-analysis
- POSTER SESSION
Improving the prognostic classification of non-muscle invasive bladder cancer with chromosome 17 polysomy and HER2 status
- POSTER SESSION
Analysis of progesterone receptor expression and promoter methylation in prostate cancer
- POSTER SESSION
Variants in CYP1A2 contribute to susceptibility of prostate cancer
- POSTER SESSION
Prediction Of Sperm Retrieval In Non-Obstructive Azoospermia Via An Artificial Intelligence Software
- POSTER SESSION
Finding patients with non-metastatic castration-resistant prostate cancer is challenging
- POSTER SESSION
Expression of RARRES1 and progression of conventional renal cell carcinoma
- POSTER SESSION
Testis sparing surgery and delayed orchiectomy: young patient with a pT1 seminoma
- POSTER SESSION
Comprehensive Patient-reported Outcomes After Female Urogenital Fistula Repair: Long term Experience From a Reconstructive Referral Center
- POSTER SESSION
WELCOME AND INTRODUCTION
- LECTURE
- 08:00 - 08:30
- 30 min
- room - IDEA 1
VARIA I
- LECTURE
- 08:30 - 09:25
- 55 min
- room - IDEA 1
Implementation of robotic programme in urological center - a crirtical analysis after first 2 years
- LECTURE
08.30-08.45
Upper Tract Urothelial Cancer (UTUC): What have we learned for 2023?
- LECTURE
08.45-09.00
The evolution of radical nephroureterectomy - from open surgery through laparoscopy/endoscopy to robot assisted
- LECTURE
09.00-09.15
Discussion
- LECTURE
09.15-09.25
BLADDER CANCER
- LECTURE
- 09:25 - 10:10
- 45 min
- room - IDEA 1
Molecular correlates of therapy sensitivity in urinary bladder cancer
- LECTURE
09.25-09.35
Perspective new intravesical therapies for NMIBC
- LECTURE
09.35-09.45
Current of systemic treatment in advanced bladder cancer
- LECTURE
09.45-09.55
Discussion
- LECTURE
09.55-10.10
PROSTATE CANCER I
- LECTURE
- 10:10 - 10:55
- 45 min
- room - IDEA 1
Screening for prostate cancer - where are we now?
- LECTURE
10.10-10.20
High risk localized prostate cancer - do we have optimal treatment options?
- LECTURE
10.20-10.30
Unmet needs in metastatic hormone sensitive prostate cancer
- LECTURE
10.30-10.40
Discussion
- LECTURE
10.40-10.55
COFFEE BREAK
- BREAK
- 10:55 - 11:15
- 20 min
PROSTATE CANCER II
- LECTURE
- 11:15 - 12:00
- 45 min
- room - IDEA 1
Protein profiling and serum analysis for the prediction of treatment resistance in metastatic castration-resistant prostate cancer
- LECTURE
11.15-11.25
Evolution in prostate cancer treatment: the role of ADT
- LECTURE
11.25-11.35
New options in treatment of advanced, treatment-refractory prostate cancer
- LECTURE
11.35-11.45
Discussion
- LECTURE
11.45-12.00
KIDNEY CANCER
- LECTURE
- 12:00 - 12:55
- 55 min
- room - IDEA 1
State of the art medical treatment for mRCC adapted to Polish reimbursement system
- LECTURE
12.00-12.10
Management of non-clear cell mRCC
- LECTURE
12.10-12.20
Management of RCC with cavathrombus
- LECTURE
12.20-12.30
Cytoreductive nephrectomy. Is it still justified?
- LECTURE
12.30-12.40
Discussion
- LECTURE
12.40-12.55
VARIA II
- LECTURE
- 12:55 - 13:40
- 45 min
- room - IDEA 1
Urological management of uretero-vaginal fistulas after hysterectomy
- LECTURE
12.55-13.05
RIRS: Comparison of complication rate between prestented and non-prestented patients
- LECTURE
13.05-13.15
Staging of lymph nodes in penile cancer - methodology and results.
- LECTURE
13.15-13.25
Discussion
- LECTURE
13.25-13.40
LUNCH
- BREAK
- 13:40 - 14:30
- 50 min
SESSION SCHOOL OF UROLOGY EDUCATION COMMITTEE OF PUA
- LECTURE
- 14:30 - 15:35
- 65 min
- room - IDEA 1
Managing discordant results between MRI and transrectal image-guided biopsies
- LECTURE
14.30-14.40
Radical prostatectomy in T3 prostate cancer
- LECTURE
14.40-14.50
Continence preservation during radical prostatectomy
- LECTURE
14.50-15.00
Post radical prostatectomy urinary incontinence treatment
- LECTURE
15.00-15.10
Lower urinary tract disfunction post radical prostatectomy
- LECTURE
15.10-15.20
From experiment to clinical practice: the value of molecular diagnostics for successful treatment of advanced prostate cancer
- LECTURE
15.20-15.35
lecture under the patronage of AstraZeneca
Discussion
- LECTURE
15.35-15.40
COFFEE BREAK
- BREAK
- 15:40 - 16:00
- 20 min
COUNTRY COMPETITION
- LECTURE
- 16:00 - 17:30
- 90 min
- room - IDEA 1
5 MIN. FOR PRESENTATION AND 10 MIN. FOR DISCUSSION
Role of surgery in oligometastatic prostate cancer: when, where, how
- LECTURE
16.00-16.15
Prostate cancer diagnostic algorithm as a “Road Map” from the first stratification of the patient to the final treatment decision
- LECTURE
16.15-16.30
Robot-assisted radical cystectomy - Why we are doing better?
- LECTURE
16.30-16.45
Outcomes of cytoreductive radical prostatectomy for oligometastatic prostate cancer diagnosed using PSMA-PET
- LECTURE
16.45-17.00
US/MR Fusion software guided vs cognitive MR targeted biopsy for detecting prostate cancer
- LECTURE
17.00-17.15
Risk factors associated with increased sperm DNA fragmentation
- LECTURE
17.15-17.30
Urinary microbiome as a potential predictor of Bacillus Calmette-Guerin (BCG) immunotherapy efficacy in nonmuscle invasive bladder cancer
- LECTURE
17.30-17.45
Adjuvant therapy in intermediate-risk non-muscle-invasive bladder cancer
- LECTURE
17.45-18.00
BREAK
- BREAK
- 18:00 - 18:15
- 15 min
AWARD SESSION, CLOSING REMARKS - GOODBYE AND FAREWELL
- LECTURE
- 18:15 - 19:00
- 45 min
- room - IDEA 1
We invite you to download the application
